Medicamen Biotech Limited (MEDICAMEQ.BO)

INR 562.7

(1.74%)

Market Cap (In INR)

7.15 Billion

Revenue (In INR)

1.79 Billion

Net Income (In INR)

109.31 Million

Avg. Volume

5110.00

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
356.75-630.0
PE
-
EPS
-
Beta Value
1.5
ISIN
INE646B01010
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Rajesh Madan B. Pharma
Employee Count
-
Website
https://medicamen.com/
Ipo Date
2005-01-12
Details
Medicamen Biotech Limited researches, develops, manufactures, markets, sells, and distributes pharmaceutical formulations and APIs in India. The company offers a range of products, including tablets, such as non-beta lactam tablets; capsules comprising beta and non-beta lactam capsules; liquid and dry syrups; and ointments and creams. It also provides oral solid and liquid products. The company's products are used in various therapeutic areas, such as gastrointestinal, pain management, anti-infectives, pediatrics, dermatology, gynecology and rheumatology, diabetology, cardiology, oncology, and the central nervous system. Medicamen Biotech Limited was incorporated in 1993 and is based in New Delhi, India.